Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study
Vahdat, Linda T, Schmid, Peter, Forero-Torres, Andres, Blackwell, Kimberly, Telli, Melinda L, Melisko, Michelle, Möbus, Volker, Cortes, Javier, Montero, Alberto J, Ma, Cynthia, Nanda, Rita, Wright, Gail S, He, Yi, Hawthorne, Thomas, Bagley, Rebecca G, Halim, Abdel-Baset, Turner, Christopher D, Yardley, Denise A
Published in NPJ breast cancer (20.05.2021)
Published in NPJ breast cancer (20.05.2021)
Get full text
Journal Article
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Yang, Zhao, Antal, Joyce M, Morris, Shannon R, O'Shaughnessy, Joyce
Published in The lancet oncology (01.11.2019)
Published in The lancet oncology (01.11.2019)
Get full text
Journal Article
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
Rugo, Hope S, Im, Seock-Ah, Cardoso, Fatima, Cortés, Javier, Curigliano, Giuseppe, Musolino, Antonino, Pegram, Mark D, Wright, Gail S, Saura, Cristina, Escrivá-de-Romaní, Santiago, De Laurentiis, Michelino, Levy, Christelle, Brown-Glaberman, Ursa, Ferrero, Jean-Marc, de Boer, Maaike, Kim, Sung-Bae, Petráková, Katarína, Yardley, Denise A, Freedman, Orit, Jakobsen, Erik H, Kaufman, Bella, Yerushalmi, Rinat, Fasching, Peter A, Nordstrom, Jeffrey L, Bonvini, Ezio, Koenig, Scott, Edlich, Sutton, Hong, Shengyan, Rock, Edwin P, Gradishar, William J
Published in JAMA oncology (01.04.2021)
Published in JAMA oncology (01.04.2021)
Get more information
Journal Article
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab
Hardesty, Melissa M., Krivak, Thomas C., Wright, Gail S., Hamilton, Erika, Fleming, Evelyn L., Belotte, Jimmy, Keeton, Erika K., Wang, Ping, Gupta, Divya, Clements, Aine, Gray, Heidi J., Konecny, Gottfried E., Moore, Richard G., Richardson, Debra L.
Published in Gynecologic oncology (01.08.2022)
Published in Gynecologic oncology (01.08.2022)
Get full text
Journal Article
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Rugo, Hope S, Im, Seock-Ah, Cardoso, Fatima, Cortes, Javier, Curigliano, Giuseppe, Musolino, Antonino, Pegram, Mark D, Bachelot, Thomas, Wright, Gail S, Saura, Cristina, Escrivá-de-Romaní, Santiago, De Laurentiis, Michelino, Schwartz, Gary N, Pluard, Timothy J, Ricci, Francesco, Gwin, 3rd, William R, Levy, Christelle, Brown-Glaberman, Ursa, Ferrero, Jean-Marc, de Boer, Maaike, Kim, Sung-Bae, Petráková, Katarína, Yardley, Denise A, Freedman, Orit, Jakobsen, Erik H, Gal-Yam, Einav Nili, Yerushalmi, Rinat, Fasching, Peter A, Kaufman, Peter A, Ashley, Emily J, Perez-Olle, Raul, Hong, Shengyan, Rosales, Minori Koshiji, Gradishar, William J
Published in Journal of clinical oncology (10.01.2023)
Published in Journal of clinical oncology (10.01.2023)
Get full text
Journal Article
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study
Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Xiao, Jie, Sorrentino, Jessica, Horton, Janet, O'Shaughnessy, Joyce
Published in Clinical cancer research (15.02.2022)
Published in Clinical cancer research (15.02.2022)
Get full text
Journal Article
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Wardley, Andrew, Cortes, Javier, Provencher, Louise, Miller, Kathy, Chien, A. Jo, Rugo, Hope S., Steinberg, Joyce, Sugg, Jennifer, Tudor, Iulia C., Huizing, Manon, Young, Robyn, Abramson, Vandana, Bose, Ron, Hart, Lowell, Chan, Stephen, Cameron, David, Wright, Gail S., Graas, Marie-Pascale, Neven, Patrick, Rocca, Andrea, Russo, Stefania, Krop, Ian E.
Published in Breast cancer research and treatment (01.05.2021)
Published in Breast cancer research and treatment (01.05.2021)
Get full text
Journal Article
Abstract P1-17-10: H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer - A phase II study
Hamilton, Erika P, Wang, Judy S, Pluard, Timothy, Morikawa, Aki, Dees, E Claire, Jones, Robert H, Haley, Barbara, Armstrong, Anne, Cohen, Adam L, Munster, Pamela, Wright, Gail S, Kayali, Fadi, Cantagallo, Lisa, Korpal, Manav, Long, Jenny, Xiao, Jianjun, Destenaves, Benoit, Gao, Lei, Sahmoud, Tarek, Gualberto, Antonio, Juric, Dejan
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis
Rugo, Hope, Im, Seock-Ah, Cardoso, Fatima, Cortes, Javier, Curigliano, Giuseppe, Musolino, Antonino, Pegram, Mark D., Bachelot, Thomas, Wright, Gail S., Saura, Cristina, Escrivá-de-Romaní, Santiago, De Laurentiis, Michelino, Schwartz, Gary N., Pluard, Timothy, Ricci, Francesco, Gwin, William, Levy, Christelle, Brown-Glaberman, Ursa, Ferrero, Jean-Marc, de Boer, Maaike, Kim, Sung-Bae, Petráková, Katarína, Yardley, Denise A., Freedman, Orit, Jakobsen, Erik H., Gal-Yam, Einav Nili, Yerushalmi, Rinat, Fasching, Peter A., Ashley, Emily, Hong, Shengyan, Rosales, Minori, Gradishar, William J.
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract PS9-11: Health-related quality of life for margetuximab + chemotherapy vs. trastuzumab + chemotherapy in the phase 3 SOPHIA trial of patients with pretreated HER2+ metastatic breast cancer
Cardoso, Fatima, Cortes, Javier, Gradishar, William, Im, Seock-Ah, Pegram, Mark D., Rugo, Hope S., Wright, Gail S., De Laurentiis, Michelino, Levy, Christelle, Ferrero, Jean-Marc, Mansi, Janine, Oyola, Raul, Ricci, Francesco, Jakobsen, Erik H., Uziely, Beatriz, Egle, Daniel, Giagounidis, Aristoteles, Williams, Kirstin, Hong, Shengyan, Rock, Edwin, Curigliano, Giuseppe
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract PD1-06: Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial
O'Shaughnessy, Joyce, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Xiao, Jie, Sorrentino, Jessica A, Horton, Janet, Tan, Antoinette R
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane
O'Shaughnessy, Joyce, Schwartzberg, Lee, Piccart, Martine, Rugo, Hope S., Yardley, Denise A, Cortes, Javier, Untch, Michael, Harbeck, Nadia, Wright, Gail S., Bondarenko, Igor, Glaspy, John, Nowecki, Zbigniew, Kayali, Fadi, Chan, Arlene, Levy, Christelle, Liu, Mei-Ching, Kim, Sung-Bae, Lemieux, Julie, Manikhas, Alexey, Tolaney, Sara, Lim, Elaine, Gombos, Andrea, Stradella, Agostina, Pegram, Mark, Fasching, Peter, Mangel, Laszlo, Semiglazov, Vladimir, Dieras, Veronique, Gianni, Luca, Danso, Michael A, Vacirca, Jeff, Kroll, Stew, O'Connell, Joseph, Tang, Kevin, Wei, Thomas, Seidman, Andrew
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract GS1-02: Phase 3 SOPHIA study of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with HER2+ metastatic breast cancer after prior anti-HER2 therapies: second interim overall survival analysis
Rugo, Hope S., Im, Seock-Ah, Cardoso, Fatima, Cortes, Javier, Curigliano, Giuseppe, Pegram, Mark D., Musolino, Antonino, Bachelot, Thomas, Wright, Gail S., De Laurentiis, Michelino, Kaufman, Peter A., Pluard, Timothy, Ricci, Francesco, Salazar, Lupe G., Yardley, Denise A., Edlich, Sutton, Hong, Shengyan, Rock, Edwin, Gradishar, William J.
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article